Gabapentin Tablet, Coated
Product Images NDC 71335-1287

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure of Gabapentin, showing a cyclohexane ring bonded to an amine group (CH2NH2) and a carboxyl group (CH2CO2H). This molecular diagram represents the active ingredient Gabapentin in its characteristic structural form.*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph depicting mean pain scores over an 8-week period, comparing placebo to gabapentin at 3,600 mg/day. The X-axis represents weeks from baseline through week 8, and the Y-axis shows mean pain scores ranging from 0 to 10. The graph highlights a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 2 (Gabapentin 03)

A line graph depicting mean pain scores over 7 weeks, comparing placebo and two dosages of gabapentin (1,800 mg/day and 2,400 mg/day). The x-axis shows weeks with a 3-week dose titration period followed by a 4-week fixed dose period, while the y-axis represents mean pain scores from 0 to 10. Data points illustrate a decline in pain scores for gabapentin groups compared to placebo.*

FDA Label Image

Figure 3 (Gabapentin 04)

A bar graph displaying results from two studies comparing placebo (PBO) and Gabapentin (GBP) at various dosages. Study 1 compares 3600 mg GBP to placebo, showing 29% vs. 12% respectively. Study 2 compares 1800 mg and 2400 mg GBP to placebo, with GBP showing 32% and 34% versus 14% placebo. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gabapentin 05)

A scatter plot chart comparing percentage difference versus daily dose (mg) for three studies labeled as study a, study b, and study c. The daily dose values on the x-axis include 600 mg, 900 mg, 1,200 mg, and 1,800 mg, and the y-axis shows difference percentages ranging from 2% to 22%. Each study is represented by a distinct marker shape and color.*

FDA Label Image

Label Image (Lbl713351287)

Gabapentin 600 mg coated tablet label packaged by Bryant Ranch Prepack, Burbank, CA. The label references Neurontin 600 mg tablet for comparison and includes storage instructions at 20°-25°C (68°-77°F), a dizziness warning, a barcode, lot number 1523487, and a package size of 30 tablets. The NDC is 71335-1287.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.